Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1985 Oct;121(1):96–101.

Myelin basic protein and P2 protein are not immunohistochemical markers for Schwann cell neoplasms. A comparative study using antisera to S-100, P2, and myelin basic proteins.

H B Clark, J J Minesky, D Agrawal, H C Agrawal
PMCID: PMC1888031  PMID: 2413766

Abstract

Immunohistochemical localization of tissue specific or cell-specific antigenic markers in neoplastic cells has become an increasingly important tool in the pathologic diagnosis of tumors. The myelin-specific proteins of peripheral nervous system myelin, because they are normally synthesized in Schwann cells, are potentially useful markers for neoplasms arising from peripheral nerves. The authors carried out immunohistochemical studies on 18 cases of Schwann cell neoplasms, including schwannomas, neurofibromas, and granular cell tumors, to determine whether two myelin-specific proteins, myelin basic protein and P2 protein, were present in neoplastic Schwann cells. None of these tumors showed immunostaining for either myelin basic protein or P2 protein in neoplastic cells. In contrast, S-100 protein, which is a well established marker for normal and neoplastic Schwann cells, was localized by immunohistochemistry to neoplastic cells in all 18 neoplasms. Therefore, although myelin basic protein and P2 protein are known to be Schwann-cell-specific proteins, they do not appear to be expressed commonly in neoplastic Schwann cells.

Full text

PDF

Images in this article

99Figure 2
on p.99
97Figure 1
on p.97
100Figure 3
on p.100

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agrawal H. C., Hartman B. K., Shearer W. T., Kalmbach S., Margolis F. L. Purification and immunohistochemical localization of rat brain myelin proteolipid protein. J Neurochem. 1977 Mar;28(3):495–508. doi: 10.1111/j.1471-4159.1977.tb10420.x. [DOI] [PubMed] [Google Scholar]
  2. Cocchia D., Michetti F., Donato R. Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature. 1981 Nov 5;294(5836):85–87. doi: 10.1038/294085a0. [DOI] [PubMed] [Google Scholar]
  3. Gaynor R., Herschman H. R., Irie R., Jones P., Morton D., Cochran A. S100 protein: a marker for human malignant melanomas? Lancet. 1981 Apr 18;1(8225):869–871. doi: 10.1016/s0140-6736(81)92142-5. [DOI] [PubMed] [Google Scholar]
  4. Gilbert W. R., Garwood M. M., Agrawal D., Schmidt R. E., Agrawal H. C. Immunoblot identification of phosphorylated basic proteins of rat and rabbit CNS and PNS myelin: evidence for four phosphorylated basic proteins and P2 in rat PNS myelin. Neurochem Res. 1982 Dec;7(12):1495–1506. doi: 10.1007/BF00965092. [DOI] [PubMed] [Google Scholar]
  5. Hartman B. K., Agrawal H. C., Kalmbach S., Shearer W. T. A comparative study of the immunohistochemical localization of basic protein to myelin and oligodendrocytes in rat and chicken brain. J Comp Neurol. 1979 Nov 15;188(2):273–290. doi: 10.1002/cne.901880206. [DOI] [PubMed] [Google Scholar]
  6. Mogollon R., Penneys N., Albores-Saavedra J., Nadji M. Malignant schwannoma presenting as a skin mass. Confirmation by the demonstration of myelin basic protein within tumor cells. Cancer. 1984 Mar 1;53(5):1190–1193. doi: 10.1002/1097-0142(19840301)53:5<1190::aid-cncr2820530527>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  7. Mukai M. Immunohistochemical localization of S-100 protein and peripheral nerve myelin proteins (P2 protein, P0 protein) in granular cell tumors. Am J Pathol. 1983 Aug;112(2):139–146. [PMC free article] [PubMed] [Google Scholar]
  8. Nakajima T., Watanabe S., Sato Y., Kameya T., Hirota T., Shimosato Y. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol. 1982 Dec;6(8):715–727. doi: 10.1097/00000478-198212000-00003. [DOI] [PubMed] [Google Scholar]
  9. Penneys N. S., Adachi K., Ziegels-Weissman J., Nadji M. Granular cell tumors of the skin contain myelin basic protein. Arch Pathol Lab Med. 1983 Jun;107(6):302–303. [PubMed] [Google Scholar]
  10. Penneys N. S., Mogollon R., Kowalczyk A., Nadji M., Adachi K. A survey of cutaneous neural lesions for the presence of myelin basic protein. An immunohistochemical study. Arch Dermatol. 1984 Feb;120(2):210–213. [PubMed] [Google Scholar]
  11. Springall D. R., Gu J., Cocchia D., Michetti F., Levene A., Levene M. M., Marangos P. J., Bloom S. R., Polak J. M. The value of S-100 immunostaining as a diagnostic tool in human malignant melanomas. A comparative study using S-100 and neuron-specific enolase antibodies. Virchows Arch A Pathol Anat Histopathol. 1983;400(3):331–343. doi: 10.1007/BF00612194. [DOI] [PubMed] [Google Scholar]
  12. Stefansson K., Wollmann R. L., Moore B. W., Arnason B. G. S-100 protein in human chondrocytes. Nature. 1982 Jan 7;295(5844):63–64. doi: 10.1038/295063a0. [DOI] [PubMed] [Google Scholar]
  13. Stefansson K., Wollmann R. L., Moore B. W. Distribution of S-100 protein outside the central nervous system. Brain Res. 1982 Feb 25;234(2):309–317. doi: 10.1016/0006-8993(82)90871-x. [DOI] [PubMed] [Google Scholar]
  14. Stefansson K., Wollmann R., Jerkovic M. S-100 protein in soft-tissue tumors derived from Schwann cells and melanocytes. Am J Pathol. 1982 Feb;106(2):261–268. [PMC free article] [PubMed] [Google Scholar]
  15. Weiss S. W., Langloss J. M., Enzinger F. M. Value of S-100 protein in the diagnosis of soft tissue tumors with particular reference to benign and malignant Schwann cell tumors. Lab Invest. 1983 Sep;49(3):299–308. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES